Clinical Trial Update: CRISPR-Edited HLA Donor Liver Transplant to Reduce Rejection [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes an investigation into CRISPR-edited HLA donor livers to reduce transplant rejection, with Phase 1 and Phase 2 studies curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Steatosis
• Liver Cancer
• Liver Cirrhosis
• Liver Failure
• Liver Metastases
• Liver Transplant Rejection

Snippet

Sponsor: AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC | Conditions: Liver Diseases, Liver Cancer | Phase 1, Phase 2 | Status: RECRUITING